Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × trifluridine tipiracil drug combination × Clear all

NCT04923529 2025-07-18

TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT05481463 2025-05-28

Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT02921737 2021-02-04

UF-STO-PANC-003

Phase 2 Terminated

7 enrolled 12 charts

Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms